Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome.
autoinflammatory diseases
clinical management
precision medicine
rare diseases
research
treatment
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2022
2022
Historique:
received:
22
04
2022
accepted:
21
06
2022
entrez:
28
7
2022
pubmed:
29
7
2022
medline:
29
7
2022
Statut:
epublish
Résumé
The aim of this paper is to present the AutoInflammatory Disease Alliance (AIDA) international Registry dedicated to Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) syndrome, describing its design, construction, and modalities of dissemination. This Registry is a clinical, physician-driven, population- and electronic-based instrument designed for the retrospective and prospective collection of real-life data. Data gathering is based on the Research Electronic Data Capture (REDCap) tool and is intended to obtain real-world evidence for daily patients' management. The Registry may potentially communicate with other on-line tools dedicated to VEXAS syndrome, thus enhancing international collaboration and data sharing for research purposes. The Registry is practical enough to be easily modified to meet future needs regarding VEXAS syndrome. To date (April 22 This international Registry for patients with VEXAS syndrome will allow the achievement of a comprehensive knowledge about this new disease, with the final goal to obtain real-world evidence for daily clinical practice, especially in relation to the comprehension of this disease about the natural history and the possible therapeutic approaches. This Project can be found on https://clinicaltrials.gov NCT05200715.
Identifiants
pubmed: 35899212
doi: 10.3389/fmed.2022.926500
pmc: PMC9309690
doi:
Banques de données
ClinicalTrials.gov
['NCT05200715']
Types de publication
Journal Article
Langues
eng
Pagination
926500Informations de copyright
Copyright © 2022 Vitale, Caggiano, Della Casa, Hernández-Rodríguez, Frassi, Monti, Tufan, Telesca, Conticini, Ragab, Lopalco, Almaghlouth, Pereira, Yildirim, Cattalini, Marino, Giani, La Torre, Ruscitti, Aragona, Wiesik-Szewczyk, Del Giudice, Sfikakis, Govoni, Emmi, Maggio, Giacomelli, Ciccia, Conti, Ait-Idir, Lomater, Sabato, Piga, Sahin, Opris-Belinski, Ionescu, Bartoloni, Franceschini, Parronchi, de Paulis, Espinosa, Maier, Sebastiani, Insalaco, Shahram, Sfriso, Minoia, Alessio, Makowska, Hatemi, Akkoç, Li Gobbi, Gidaro, Olivieri, Al-Mayouf, Erten, Gentileschi, Vasi, Tarsia, Mahmoud, Frediani, Fares Alzahrani, Laymouna, Ricci, Cardinale, Jahnz-Rózyk, Tosi, Crisafulli, Balistreri, Dagostin, Ghanema, Gaggiano, Sota, Di Cola, Fabiani, Giardini, Renieri, Fabbiani, Carrer, Bocchia, Caroni, Rigante and Cantarini.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Allergy Clin Immunol. 2022 Jan;149(1):432-439.e4
pubmed: 34048852
Ophthalmol Ther. 2022 Apr;11(2):899-911
pubmed: 35099782
Blood Adv. 2021 Aug 24;5(16):3203-3215
pubmed: 34427584
Br J Haematol. 2021 Oct;195(2):286-289
pubmed: 34340250
Pharmaceut Med. 2020 Jun;34(3):185-190
pubmed: 32215853
Int J Environ Res Public Health. 2018 Aug 03;15(8):
pubmed: 30081484
Ann Rheum Dis. 2015 Sep;74(9):1636-44
pubmed: 26109736
Funct Integr Genomics. 2022 Jun;22(3):291-315
pubmed: 35098403
Front Immunol. 2021 Apr 23;12:678927
pubmed: 34046042
N Engl J Med. 2020 Dec 31;383(27):2628-2638
pubmed: 33108101
Orphanet J Rare Dis. 2017 Oct 18;12(1):167
pubmed: 29047407
Ophthalmol Ther. 2022 Apr;11(2):887-897
pubmed: 35092604
Front Med (Lausanne). 2022 Apr 07;9:878797
pubmed: 35463015